Biggest News Aggregation in the World
📰 Valuating News

Page 6 - Valuating News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Valuating. Real-time updates on events, politics, business and more.

MyJournals.org - Science - 'Remote Sensing, Vol. 15, Pages 2094: Evaluating the Losses and Recovery of GPP in the Subtropical Mangrove Forest Directly Attacked by Tropical Cyclone: Case Study in Hainan Island' (Remote Sensing)

MyJournals.org - Science - Remote Sensing, Vol. 15, Pages 2094: Evaluating the Losses and Recovery of GPP in the Subtropical Mangrove Forest Directly Attacked by Tropical Cyclone: Case Study in Hainan Island (Remote Sensing)
Hainan Island

Shanghai Cellular Biopharmaceutical Group Ltd.: Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting

Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 17, 2023 /PRNewswire/ -- Shanghai Cellular
United States Orange County Convention Center Sarah Kelly Company Contact American Association For Cancer Research Prnewswire Shanghai Cellular Biopharmaceutical Group Ltd

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BELLUS Health Inc. Announces Positive Results from Its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation of Camlipixants

BELLUS Health Inc. announced positive data from its Phase 1 bioavailability equivalence study evaluating a once-daily Extended-Release formulation of camlipixant in comparison to a twice-daily... | April 6, 2023
Bellus Health Inc Immediate Release Bellus Health Inc Stock Exchange Press Release O Blu Ca07987c2040

CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

Continued advancement of global patient enrollment with approvals and site activations in the U.S., Switzerland, France, Spain and ItalyEnrollment continuing to progress toward an interim analysis expected
United States John Climaco Jenene Thomas Securities Exchange Pharmaceuticals Inc View Competent Authority

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science